Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2025-12-24 @ 12:05 PM
NCT ID:
NCT00474461
Eligibility Criteria:
Inclusion Criteria:
* LVEF \< 40% (by any imaging modality: echocardiography/SPECT/LV angiography)
* A history of Q-wave MI with a residual akinetic and nonviable scar (as evidenced by low-dose dobutamine stress echocardiogram and/or or thallium redistribution nuclear study for viability and/or an electrocardiogram)
* Patients scheduled for surgical revascularization within few days (\< 2 weeks) of the initial screening
Exclusion Criteria:
* Age \>75 by time of infusion
* Cardiogenic shock
* Severe co-morbidities (e.g., renal failure, liver failure)
* Mini-CABG procedures
* Pregnant/nursing women or women of child-bearing potential
* Inability to provide informed consent
* Diabetic Hgb A1c \> 8.5%
* Patients with a history of hepatitis B, hepatitis C, and HIV
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00474461
Study Brief:
Protocol Section:
NCT00474461